Navigation Links
Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC
Date:5/31/2011

related to any future investments will be based on the prevailing market prices of Bacterin's common shares immediately preceding the notice of sale to LPC without any fixed discount.  The Company controls the timing and amount of any future investment and LPC is obligated to make purchases, if and when the Company decides, in accordance with the purchase agreement.  There are no penalties or liquidated damages in the purchase agreement. The agreement may be terminated by the Company at any time, at its sole discretion, without any cost or penalty.

A more detailed description of the agreement is set forth in the Company's Current Report on Form 8-K recently filed with the SEC on May 31, 2011 which the Company encourages to be reviewed carefully.  The securities offered have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.  This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering nor will there be any sale of these securities in any jurisdiction in which such offer solicitation or sale are unlawful prior to registration or qualification under securities laws of any such jurisdiction.

About Bacterin International Holdings, Inc.

Bacterin International Holdings, Inc. ("the "Company" or "Bacterin") develops, manufactures and markets biologics products to domestic and international markets.  Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth.  These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondra
'/>"/>

SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bacterin International Completes $3 Million Private Placement
2. Bacterin International Introduces OsteoSelect(R) DBM Putty
3. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
4. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
5. Bacterin International Holdings, Inc. to Present at the 6th Annual Fall Growth Stock Conference Hosted by Security Research Associates, Inc.
6. Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
7. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
8. Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results
9. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
10. Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
11. Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  UL (Underwriters ... that the U.S. Food and Drug Administration (FDA) ... consensus standards for medical devices incorporating lithium or ... - Standard for Household and Commercial Batteries, and ... Consensus standards are standards recognized ...
(Date:7/22/2014)... 2014  NeuroSigma, Inc. (NeuroSigma), a California ... its non-invasive Monarch ™ eTNS™ Therapy ... announced that enrollment has begun in a pediatric open ... adjunctive therapy for the treatment of Lennox-Gastaut Syndrome (LGS). ... Olive View-UCLA Medical Center in Sylmar, California ...
(Date:7/22/2014)... OXFORD, England , July 22, 2014 /PRNewswire/ ... pharmaceutical development and device company focused on solid ... that its novel solid formulation of octreotide acetate ... comparing it with the currently marketed liquid product ... to transfer the formulation production process to a ...
Breaking Medicine Technology:Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2
(Date:7/22/2014)... CyraCom has been ranked as North America’s 6th largest ... industry. Released June 2014 by the market research firm ... Market: 2014," also ranked CyraCom as the 18th ... from 2013. , In 2013, Common Sense Advisory also ... – a subset of the language service industry. CyraCom ...
(Date:7/22/2014)... New York (PRWEB) July 22, 2014 ... new market report based on Molecular Diagnostics Market – ... to 2019 in addition to their comprehensive database. This ... market for clinical applications. It is valued at USD ... a CAGR of 11.1% from 2013 to 2019. Molecular ...
(Date:7/22/2014)... 22, 2014 University of the ... opened the doors of its state-of-the-art, $151 million campus ... heart of downtown San Francisco's South of Market (SoMa) ... a year. Those patients will now be greeted by ... iKiosks . , Advanced Kiosks engineering team designed ...
(Date:7/22/2014)... Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer ... for one of the most complex and difficult-to-treat ... , Locally advanced pancreatic cancer has the ... a cumulative five-year survival rate of only 4 ... rarely an option for patients because tumors often ...
(Date:7/22/2014)... SkillSurvey Inc., the leading provider ... make better hiring decisions, will be delivering a ... engagement and retention of contingent workers at the ... Conference being held in Orlando, Florida on July ... study featuring Metro Health, a hospital in Grand ...
Breaking Medicine News(10 mins):Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:SkillSurvey to Present Research on Contingent Workers at National Association for Health Care Recruitment IMAGE 2014 Conference 2
... can determine the gentleness of a surgeon while performing a ... and colleague//. ,The invention of Dr Vijay Maker, ... and Dr Joseph Talarico, a surgical resident at the same ... development. While the original idea is Maker's, Talarico designed the ...
... is time for impatient patients to travel abroad rather than ... ailments. Recently, a woman won the right to claim compensation ... In yet another case, a 63-year-old British woman who traveled ... confirmed absence of any genetic disorder. ,A recent ...
... in Japan has found migraine medication sumatriptan, known by ... for pain// due to trigeminal neuralgia up to eight ... migraine medication could provide relief for people who suffer ... found it produced rapid and significant pain relief without ...
... Tamil Nadu Hindu Religious and Charitable Endowment Minister P T ... a train and died at a private hospital at Dindigul ... from the Madurai Central Constituency, was also the speaker of ... survived by his wife Rukmani and a son, who is ...
... is found that there is an increase in number of ... action// to tackle young criminals. According to the statistics the ... criminal offences due to alcohol increased by more than 150 ... crimes and theft. But the figures of the number of ...
... Indiana University Bloomington have reported that mouse sperm cells ... cells were bang on target, even when ovary extracts ... exhibit chemotaxis toward extracts from various female reproductive organs, ... known," said IUB Associate Professor of Chemistry Stephen C. ...
Cached Medicine News:Health News:Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain 2Health News:Sperm Cells attracted By Ovary Scent, Even in Weakened State 2
... In certain hernia and soft tissue ... fascial defects, it is sometimes necessary ... one surface, while minimizing tissue attachment ... a soft, conformable, ePTFE sheet material ...
... Bard Dulex mesh is a dual-sided ePTFE ... side is a micro-porous structure designed to minimize ... side is a macro-porous structure designed to promote ... size of approximately 800 microns, which is nearly ...
... mesh is the first polypropylene mesh ... Visilex mesh directly addresses the critical ... specifically, it delivers maximum visibility, enhanced ... after insertion through the trocar.,Visilex mesh ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: